- Home
- EBS vs NX Comparison
EBS vs NX Comparison
Compare EBS & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBS | NX |
|---|---|---|
| Founded | 1998 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.6M | 797.0M |
| IPO Year | 2006 | 2008 |
Fundamental Metrics
Financial Performance| Metric | EBS | NX |
|---|---|---|
| Price | $8.39 | $17.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 1.0M | 493.5K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.84% |
| EPS Growth | ★ 125.83 | N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | $742,900,000.00 | ★ $1,837,641,000.00 |
| Revenue This Year | $29.50 | $3.18 |
| Revenue Next Year | N/A | $2.27 |
| P/E Ratio | $8.89 | ★ N/A |
| Revenue Growth | N/A | ★ 43.81 |
| 52 Week Low | $4.02 | $11.04 |
| 52 Week High | $14.06 | $22.90 |
Technical Indicators
Market Signals| Indicator | EBS | NX |
|---|---|---|
| Relative Strength Index (RSI) | 30.16 | 27.59 |
| Support Level | $7.66 | $16.09 |
| Resistance Level | $9.68 | $19.88 |
| Average True Range (ATR) | 0.58 | 0.89 |
| MACD | -0.21 | -0.66 |
| Stochastic Oscillator | 15.48 | 7.41 |
Price Performance
Historical ComparisonAbout EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.